Senior insider sale
General Counsel at CENTESSA PHARMACEUTICALS PLC — senior position signals high conviction
$1.20M
64K shares
What this filing means
HUSSAIN IQBAL J plans to sell 64K shares of CENTESSA PHARMACEUTICALS PLC valued at approximately $1.20M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/10/2025ACC: 0001969223-25-000753
Officer· General Counsel
Since May 2021
64K
Shares to sell
$1.20M
Approx. market value
20K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
9/10/2025
20KTotal acquired20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/10/2025 | Exercise of Stock Options Cash | 20K | — |
| Total | 20K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
20K
Market value
$400.1K
9/9/2025
—Completed
Units to sell
6K
Market value
$103.4K
8/15/2025
—Completed
Units to sell
6K
Market value
$89.6K
7/15/2025
—Completed
Units to sell
12K
Market value
$168.2K
6/24/2025
Planned — Approximate Date
NasdaqPlanned
Units to sell
20K
Market value
$440.0K
9/10/2025
Total
Units
64K
Value
$1.20M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/9/2025 | 20K | $400.1K | — | Completed |
8/15/2025 | 6K | $103.4K | — | Completed |
7/15/2025 | 6K | $89.6K | — | Completed |
6/24/2025 | 12K | $168.2K | — | Completed |
| Planned — Approximate Date | ||||
9/10/2025 | 20K | $440.0K | Nasdaq | Planned |
| Total | 64K | $1.20M | ||